MedPath

melatonin in neonates with hypoxic encephalopathy

Phase 1
Recruiting
Conditions
Hypoxic ischemic encephalopathy [HIE].
Hypoxic ischemic encephalopathy [HIE]
P91.6
Registration Number
IRCT20230605058385N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

neonates with pregnancy age more than 32 weeks
diagnosis hypoxic ischemic encephalopathy
parent consent

Exclusion Criteria

congenital malformations
congenital infections
maternal chorioamnionitis
heretical encephalopathy
metabolic encephalopathy
hyperbilirobinemic encephalopathy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pro-Oxidant Antioxidant Balance. Timepoint: three days after birth. Method of measurement: Pro-Oxidant Antioxidant Balance (PAB) assay.
Secondary Outcome Measures
NameTimeMethod
Pro-Oxidant Antioxidant Balance. Timepoint: seven days after birth. Method of measurement: Pro-Oxidant Antioxidant Balance (PAB) assay.
Âİ Copyright 2025. All Rights Reserved by MedPath